Zelmic’s have a strong track record of bringing topical products from idea to clinical testing. We have inhouse formulation, GMP analytical chemistry, and in vitro release capability to bring value to the drug development companies and can handle small molecules, peptides, and proteins. Moreover, Zelmic’s team members have been working with drug delivery technologies and have put both oral, parental, and dermatological products on the market. The profound expertise in the topical-formulation niche is a strong differentiating factor to larger competing CRO’s.
- Bli medlem
- Om SwedenBIO